{
  "id": 19177623,
  "title": "Watch: Where Do Our Generic Drugs Come From? We Dug to Find Out.",
  "url": "https://urgent.news/2026/11/09/watch-where-do-our-generic-drugs-come-from-we-dug-to-find-out",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-09T15:55:00.000Z",
  "source": {
    "name": "ProPublica",
    "slug": "propublica",
    "url": "https://www.propublica.org/article/generic-prescription-drug-supply-fda-explained"
  },
  "original_language": "en",
  "account": "The majority of prescription medications prescribed in the United States are generic drugs, which are typically more affordable than their brand-name counterparts. However, a recent 14-month investigation into the origin of these generic drugs has revealed troubling conditions at the factories where they are produced. India is responsible for producing about half of all generic drugs used in the U.S., but manufacturers often do not disclose where a drug was made on the pill bottle labels.\n\nInspection reports have uncovered numerous issues at generic drug factories, including unsanitary conditions, mold, foul water, blackish vials of medication, and even metal shavings on equipment. In some cases, inspectors reported that records were manipulated to hide the presence of contaminants like glass or fibers in the medication. In one particularly alarming incident, a drug manufacturer acid-washed records to cover up particulate matter.\n\nThese unsafe practices have led to serious consequences for patients. In one tragic case, a transplant patient named Hannah Goetz, who required daily doses of a generic drug called tacrolimus, suffered a lung failure and died at the age of 21 after taking generic versions of the drug from two manufacturers with documented problems. While lawyers could not directly link her death to a specific generic drug manufacturer, her mother remains concerned that a different brand of tacrolimus could have saved her daughter's life.\n\nIn response to ProPublica's investigation, the FDA stated that the exemptions given to banned factories are subject to a comprehensive evaluation process. However, the agency did not disclose the specifics of these evaluations or how they ensure the safety of generic drugs. The FDA also claimed that it requires manufacturers to conduct additional quality checks with third-party oversight before importing drugs into the U.S., but failed to provide details on how they can be confident in the safety of generics without a more robust testing program.\n\nProPublica's investigation, which was recognized as a finalist for the Pulitzer Prize for investigative reporting, concluded with the release of an interactive tool called Rx Inspector. This tool allows patients to search for the facility that manufactured their generic prescription drugs and view any inspection reports, warning letters, or import bans issued by the FDA. However, the tool is not without limitations, as the FDA's data may not be entirely comprehensive and companies can change ownership or move facilities. Nonetheless, the tool provides patients with a starting point to understand the origins of their medications and to discuss any concerns with their healthcare provider.",
  "summary": "The post Watch: Where Do Our Generic Drugs Come From? We Dug to Find Out. appeared first on ProPublica .",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}